In pathological conditions such as cancer, colitis, and autoimmune diseases, activation of the IL11–JAK/STAT3 axis promotes inflammation, tissue remodeling, and even immunosuppression within the tumor microenvironment (38, 44). This evidence concerns the gene IL11 and neoplasm.